Tuberculosis

One-third of the world’s population is currently infected with the TB bacillus but they have a latent form of the disease and so have no symptoms and cannot transmit it. In some people, the latent TB infection progresses to acute TB, often due to a weak immune system. Every year, about nine million people develop active TB and 1.5 million die from it.

TB is spread through the air when infected people cough or sneeze. Not everyone infected with TB becomes ill, but 10 per cent will develop active TB at some point in their lives. The disease most often affects the lungs. Symptoms include a persistent cough, fever, weight loss, chest pain and breathlessness in the lead-up to death. TB incidence is much higher, and is a leading cause of death, among people with HIV.

Diagnosis of TB depends on a sputum or gastric fluid sample, which can be difficult to obtain from children. A new molecular test that can give results after just two hours and detect a certain level of drug resistance is now being used, but it is costly and still requires a phlegm sample, as well as a reliable power supply.

A course of treatment for uncomplicated TB takes a minimum of six months. When patients are resistant to the two most powerful first-line antibiotics (isoniazid and rifampicin), they are considered to have multidrug-resistant TB (MDR-TB). MDR-TB is not impossible to treat, but the drug regimen is arduous, taking up to two years and causing many side effects. Extensively drug-resistant tuberculosis (XDR-TB) is identified when patients show resistance to the second-line drugs administered for MDR-TB. The treatment options for XDR-TB are very limited.

In 2014, MSF treated 21,500 patients for TB, of which 1,800 for MDR-TB.

Updates
A recent survey shows that the national programme’s vaccination coverage for all antigens has...
Press release
"If the measures in this agreement prevent people from getting the generic medicines they need, the...
Press release
MSF urges Indian Prime Minister not to cave to pressure from EU to accept trade deal that could...
Press release
“TB is curable, yet it is now the infectious disease that kills the most people in the world,” said...
Press release
“Return to Abuser” report uncovers the gaps in services and systems trapping women and children in...
Press release
"The price for delamanid needs to come down to an affordable level, and Otsuka should also register...
Press release
MSF appreciates Otsuka Pharmaceuticals’ donation of 400 treatments of a novel drug, delamanid,...
Report
Download the complete report (pdf) Geneva/Cape Town – Médecins Sans Frontières (MSF) and the...
Updates
Médecins Sans Frontières (MSF) employs more than 2,937 South Sudanese staff and 329 international...
Updates
Article
The decision of the Humanitarian Committee of the self-proclaimed DPR authorities is leaving 146...
Press release
“African leaders really should see this summit as an opportunity to work together with Prime...
Article
MSF strongly refutes the false allegations made in the media by the Humanitarian Committee of DPR...
Press release
MSF has received written notification from the Humanitarian Committee that its accreditation in the...
Article
PNG's Gulf Province is largely a land without Land Cruisers, the four-wheeled workhorses used by...
Press release
“We need affordable medicines from India to do our humanitarian work, so we are not about to let...
Op-ed
"In order to stand a better chance to achieve the SDG targets by 2030, domestic resources for...

Pages